Carmichael J, Shankel S W
Am J Med. 1985 Jun;78(6 Pt 1):992-1000. doi: 10.1016/0002-9343(85)90223-2.
In the past 15 years, there has been an explosion in the number of nonsteroidal anti-inflammatory drugs on the market. Along with this explosion have come increasing reports of the physiologic and pathologic changes seen in the kidneys. This report reviews the effects of prostaglandins on the kidney and the physiologic changes that result when prostaglandin synthesis is blocked. The world literature on renal complications of nonsteroidal anti-inflammatory drugs is reviewed and 274 cases of acute renal disease associated with their use are reported. The following cases are described: nephrotic syndrome (34); acute interstitial nephritis (51); acute tubular necrosis (29); papillary necrosis (53); poor perfusion with renal failure (40); acute glomerulitis or vasculitis (13); and unspecified renal failure (102). Fenoprofen appeared to be more nephrotoxic than other nonsteroidal anti-inflammatory drugs and resulted in multiple renal lesions in the same patient.
在过去15年里,市场上非甾体抗炎药的数量呈爆炸式增长。与此同时,关于肾脏出现的生理和病理变化的报道也越来越多。本报告回顾了前列腺素对肾脏的影响以及前列腺素合成受阻时所导致的生理变化。对关于非甾体抗炎药肾脏并发症的世界文献进行了综述,并报告了274例与之相关的急性肾病病例。描述了以下病例:肾病综合征(34例);急性间质性肾炎(51例);急性肾小管坏死(29例);乳头坏死(53例);灌注不良伴肾衰竭(40例);急性肾小球炎或血管炎(13例);以及未明确的肾衰竭(102例)。非诺洛芬似乎比其他非甾体抗炎药具有更强的肾毒性,且会在同一患者身上导致多种肾脏病变。